Wells Fargo & Company Avanos Medical, Inc. Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 114,537 shares of AVNS stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114,537
Previous 104,830
9.26%
Holding current value
$1.41 Million
Previous $1.67 Million
1.62%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AVNS
# of Institutions
298Shares Held
43.3MCall Options Held
3.5KPut Options Held
13.2K-
Black Rock Inc. New York, NY7.01MShares$86.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$65.7 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.76MShares$46.1 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.6MShares$31.9 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2MShares$24.6 Million0.44% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $571M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...